Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders



Page Path
HOME > Search
3 "Rabani Remli"
Article category
Publication year
Brief communication
Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review
Kah Hui Yap, Nurul Husna Baharudin, Abdul Halim Abdul Gafor, Rabani Remli, Shen-Yang Lim, Wan Asyraf Wan Zaidi, Shahrul Azmin, Shahizon Azura Mohamed Mukari, Raihanah Abdul Khalid, Norlinah Mohamed Ibrahim
J Mov Disord. 2022;15(3):258-263.   Published online May 26, 2022
  • 3,019 View
  • 107 Download
AbstractAbstract PDFSupplementary Material
The basal ganglia (BG) are susceptible to fluctuations in blood urea levels, sometimes resulting in movement disorders. We described patients with end-stage kidney disease (ESKD) presenting with movement disorders associated with bilateral BG lesions on imaging.
We report four patients and systematically reviewed all published cases of ESKD presenting with movement disorders and bilateral BG lesions (EBSCOhost and Ovid).
Of the 72 patients identified, 55 (76.4%) were on regular dialysis. Parkinsonism was the most common movement disorder (n = 39; 54.2%), followed by chorea (n = 24; 33.3%). Diabetes mellitus (n = 51; 70.8%) and hypertension (n = 16; 22.2%) were the most common risk factors. Forty-three (59.7%) were of Asian ethnicity. Complete clinical resolution was reported in 17 (30.9%) patients, while 38 (69.1%) had incomplete clinical resolution with relapse. Complete radiological resolution occurred in 14 (34.1%) patients.
Movement disorders associated with BG lesions should be recognized as a rare and potentially reversible metabolic movement disorder in patients with ESKD.
Case Report
Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review
Chun-Yang Sim, Shahizon Azura Mohamed Mukari, Lock-Hock Ngu, Chia-Yin Loh, Rabani Remli, Norlinah Mohamed Ibrahim
J Mov Disord. 2022;15(2):162-166.   Published online December 24, 2021
  • 4,529 View
  • 307 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary Material
Labrune’s syndrome, or leukoencephalopathy with brain calcifications and cysts (LCC), is a rare genetic syndrome with variable neurological presentations. Psychiatric manifestations and involuntary movements are uncommonly reported. We report the case of a 19-year-old female, initially diagnosed with Fahr’s syndrome, who presented to us with acute psychosis, abnormal behavior and involuntary movements. Her brain computed tomography showed extensive bilateral intracranial calcifications without cysts. Genetic testing detected two compound heterozygous variants, NR_033294.1 n.*9C>T and n.24C>T, in the SNORD118 gene, confirming the diagnosis of LCC. We discuss the expanding phenotypic spectrum of LCC and provide a literature review on the current diagnosis and management of this rare syndrome.


Citations to this article as recorded by  
  • Leukoencephalopathy, calcifications, and cysts: Labrune syndrome
    Andrew Waack, Jordan Norris, Kathryn Becker, Alastair Hoyt, Jason Schroeder
    Radiology Case Reports.2023; 18(2): 584.     CrossRef
  • Leukoencephalopathy with calcifications and cysts: A case report with literature review
    Jingya Li, Chun Li, Qing Zhang, Chao Qiu
    Neurological Sciences.2023; 44(8): 2715.     CrossRef
  • Adult-Onset Genetic Leukoencephalopathies With Movement Disorders
    Mu-Hui Fu, Yung-Yee Chang
    Journal of Movement Disorders.2023; 16(2): 115.     CrossRef
  • Expanding the Natural History of SNORD118-Related Ribosomopathy: Hints from an Early-Diagnosed Patient with Leukoencephalopathy with Calcifications and Cysts and Overview of the Literature
    Davide Politano, Guido Catalano, Elena Pezzotti, Costanza Varesio, Fabio Sirchia, Antonella Casella, Elisa Rognone, Anna Pichiecchio, Renato Borgatti, Simona Orcesi
    Genes.2023; 14(9): 1817.     CrossRef
  • Case report: Clinical and neuroradiological longitudinal follow-up in Leukoencephalopathy with Calcifications and Cysts during treatment with bevacizumab
    Elena Scaffei, Bianca Buchignani, Rosa Pasquariello, Paola Cristofani, Raffaello Canapicchi, Laura Biagi, Flavio Giordano, Emanuela De Marco, Yanick J. Crow, Roberta Battini
    Frontiers in Neurology.2023;[Epub]     CrossRef
Letter to the editor
Anti-GABAB Receptor Encephalitis Presenting with Atypical Corticobasal Syndrome in a Patient with Parkinson’s Disease
Noor Sharizat Abdullah, Tan Hui Jan, Rabani Remli, Shahizon Azura Mohamad Mukari, Norlinah Mohamed Ibrahim
J Mov Disord. 2020;13(3):235-237.   Published online September 9, 2020
  • 6,677 View
  • 86 Download
  • 2 Web of Science
  • 2 Crossref


Citations to this article as recorded by  
  • Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships
    Maria Pia Giannoccaro, Federico Verde, Luana Morelli, Giovanni Rizzo, Fortuna Ricciardiello, Rocco Liguori
    Biomedicines.2023; 11(3): 666.     CrossRef
  • Neuronal Antibody-Associated Corticobasal Syndrome
    Anu Gupta, Roopa Rajan, Shiny Joy, Chitrangada Shivaji Yadav, Madhavi Tripathi, Shailesh B. Gaikwad, Vishnu VY, Mamta B. Singh, Rohit Bhatia, Anita Mahadevan, Madakasira Vasantha Padma Srivastava
    Annals of Indian Academy of Neurology.2023; 26(5): 787.     CrossRef

JMD : Journal of Movement Disorders Twitter